|
|
Volumn 2014, Issue , 2014, Pages
|
|
Novel drugs development for cardio-/cerebrovascular diseases
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMAROGENTIN;
ANISODAMINE;
CARDIOVASCULAR AGENT;
CENTRAL NERVOUS SYSTEM AGENTS;
CYTOCHROME P450 INHIBITOR;
ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE];
HERBACEOUS AGENT;
IMIDAZOLINE I1 RECEPTOR;
LIPOXYGENASE INHIBITOR;
MACROPHAGE MIGRATION INHIBITION FACTOR;
NITRIC OXIDE SYNTHASE INHIBITOR;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
PROSTAGLANDIN SYNTHASE INHIBITOR;
CARDIOVASCULAR DISEASE;
CEREBROVASCULAR DISEASE;
EDITORIAL;
HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE;
HEART LEFT VENTRICLE PRESSURE;
HEART MUSCLE CONTRACTILITY;
HEART MUSCLE ISCHEMIA;
HEART PROTECTION;
HUMAN;
HYPERTENSION;
NONHUMAN;
OXIDATIVE STRESS;
PROTEIN EXPRESSION;
REPERFUSION INJURY;
TETRADIUM RUTICARPUM;
THROMBOCYTE ACTIVATION;
THROMBOCYTE RICH PLASMA;
CARDIOVASCULAR DISEASES;
CEREBROVASCULAR DISORDERS;
DRUG DEVELOPMENT;
DRUG EFFECTS;
HEART;
CARDIOVASCULAR DISEASES;
CEREBROVASCULAR DISORDERS;
DRUG DISCOVERY;
HEART;
HUMANS;
|
|
EID: 84904205660
PISSN: 23146133
EISSN: 23146141
Source Type: Journal
DOI: 10.1155/2014/467936 Document Type: Editorial |
|
Times cited : (7)
|
|
References (0)
|
